dyshidrosiform pemphigoid
Jump to navigation
Jump to search
Epidemiology
- rare, elderly
Pathology
- skin biopsy
- subepidermal blisters with eosinophilic infiltration
- direct immunofluorescence reveals strong linear fluorescence with continuous deposition along the basement membrane zone, C3 positive, IgA & IgM negative
- IgE-activated mast cells, basophils, & eosinophils may play a role in inducing pruritus, blister formation & reduced response to systemic glucocorticoids
* images[1]
Clinical manifestations
- recurrent itching & tense blisters on both hands
- recurrent or persistent vesicular eruptions resembling pompholyx
- hemorrhagic or purpuric features, particularly in elderly
- blisters most commonly found on both the palms & soles (67%), soles only (30%), or palms only (3%), with 72% progressing elsewhere.
* image[1] Labroatory;
- epidermal basement membrane IgG Ab in serum
- ELISA using antibodies to bullous pemphigoid autoantigen-2 (COL171A, BP180)
- anti BP230 (gene on 6p) [homology with desmoplakin]
- IgE in serum
Diagnostic procedures
Management
- oral methylprednisolone 8 mg QD for 7 days
- oral minocycline 50 mg BID +
- nicotinamide 200 mg TID +
- dupilumab 300 mg SQ biweekly for 3 months
More general terms
References
- ↑ 1.0 1.1 1.2 Hu W, Du S. Gao M Hand Blisters. Dyshidrosiform Pemphigoid. Mayo Clinic Proceedings. 2025. 100(9):p1471-1472 https://www.mayoclinicproceedings.org/article/S0025-6196(25)00208-3/fulltext
- ↑ Cohen PR. Dyshidrosiform Bullous Pemphigoid: Case Reports and Review. Cureus. 2020 Jan 11;12(1):e6630. doi:http://dx.doi.org/ 10.7759/cureus.6630. PMID: https://pubmed.ncbi.nlm.nih.gov/32064205 PMCID: PMC7008730 Free PMC article.